Pulsenmore Ltd. (PLSM)
| Market Cap | 40.06M |
| Revenue (ttm) | 2.76M |
| Net Income (ttm) | -13.06M |
| Shares Out | 6.43M |
| EPS (ttm) | -2.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,170 |
| Open | 9.45 |
| Previous Close | n/a |
| Day's Range | 6.35 - 10.28 |
| 52-Week Range | 6.35 - 10.28 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 27, 2026 |
About PLSM
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel. [Read more]
Financial Performance
In 2024, Pulsenmore's revenue was 9.66 million, an increase of 56.12% compared to the previous year's 6.19 million. Losses were -36.74 million, -37.28% less than in 2023.
Financial numbers in ILS Financial StatementsNews
Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at ...